nDatalyze Corp. fell 42.9% on Monday, November 9, 2026, on 5,000 shares, 26 times its average daily volume. No headline about NDAT came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
nDatalyze Corp. (NDAT:CSE) closed at $0.030 on November 11, 2026, unchanged on the day. The stock trades 85.0% below its 52-week high of $0.200 and 100.0% above its 52-week low of $0.015. nDatalyze Corp. is part of the Life Sciences sector.
In 252 trading sessions since November 12, 2025, NDAT closed higher on 17 days (7%). Its best day was March 13, 2026 (+150.00%) and its worst was November 9, 2026 (-42.86%). The stock moved 10% or more in a single session 32 times. It opened at least 5% above the previous day's high 17 times.
The Corporation is a Calgary-based company that recently initiated its new SHAMAN development; a validated-data-driven, machine-learning mHealth platform designed to provide, initially, proactive analysis of the potential of psychedelics in mental health treatment regimes. MXT derives cash flow from the manufacture and sale of it's patented craft-scale bio-extractors that can be used to extract compounds from a variety of botanical materials.
Find more stocks like NDAT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.